Correlation Between Scpharmaceuticals and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Tempest Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Tempest Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Tempest Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Scpharmaceuticals and Tempest is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Tempest Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Tempest Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 2.44 times less risky than Tempest Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Tempest Therapeutics is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 72.00 in Tempest Therapeutics on October 20, 2024 and sell it today you would earn a total of 21.00 from holding Tempest Therapeutics or generate 29.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Tempest Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Tempest Therapeutics |
Scpharmaceuticals and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Tempest Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world |